Side-Effect Management

Music Therapy Is Appreciated but Poorly Understood Among Clinicians

By

Vicki Moore, PhD

Despite having a high awareness of music therapy, many clinicians do not understand how it works or how to refer patients.

Mock Emergency Drills at an Outpatient Oncology Clinic Ensures Staff Preparedness for Critical Situations

By

Susan Moench, PhD, PA-C

Mock emergency drills conducted at an ambulatory cancer center focused on scenarios dealing with respiratory distress, stroke, and use of an evacuation chair to ensure staff had experience reacting to these emergencies.

Assessment for Vulnerability Improves Outcomes for Patients With HNC Undergoing Concurrent Chemoradiotherapy

By

Vicki Moore, PhD

Comprehensive geriatric assessment was shown to effectively identify vulnerability to AEs in patients with HNC across all ages.

ASCO Endorses CCO Guideline on Bone Health and Bone-Targeted Therapies in Prostate Cancer

By

Susan Moench, PhD, PA-C

Although all recommendations were endorsed, an expert panel also added discussion points regarding treatments for reducing skeletal-related events in and improving survival in patients with bone metastases.

Long-Term Improvement in Distress Achieved With Psilocybin in Patients With Life-Threatening Cancer

By

Vicki Moore, PhD

All patients in this study reported positive behavioral change as much as 4.5 years after treatment with a single dose of psilocybin.

Multiple Factors Associated With Hospital Readmission Following Pancreatectomy for Cancer

By

Susan Moench, PhD, PA-C

Results of this study showed no improvement in the rate of 30-day hospital readmission for patients with cancer undergoing pancreatectomy between 2005 and 2011.

Anorexia, Hypertension, Pneumothorax, and Hypothyroidism: Potential Signs of Improved Clinical Outcome Following Apatinib in Advanced Osteosarcoma

[Cancer Management and Research] A single-institution study that evaluated the efficacy and safety of apatinib, a specific TKI, in patients aged 16 years and older with advanced osteosarcoma progressing on chemotherapy showed that some AEs may be markers for improved PFS and clinical benefit rate.

Nurse-Led Oncology Fast-Track Clinic for Children Treated With Chemotherapy Shows Promising Early Results

By

Susan Moench, PhD, PA-C

Outpatient management via an OFTC resulted in a more specialized, targeted approach to complications/side effects in pediatric patients undergoing chemotherapy and fewer hospital admissions.

A PRO Tool for Assessing Treatment-Related Side Effects of Immune Checkpoint Modulator Therapy Is in Development

By

Susan Moench, PhD, PA-C

Immune-related adverse events are experienced by many patients receiving immune checkpoint modulators (ICMs) and can manifest in a wide range of organ systems.

Lower Dose Olanzapine Plus Triplet Antiemetic Therapy May Reduce Chemotherapy-Induced Nausea and Vomiting

By

Susan Moench, PhD, PA-C

Olanzapine added to triplet antiemetic therapy, has been shown to reduce risk of chemotherapy-induced nausea and vomiting, but can cause daytime sleepiness.